Mark Andres
Inventor
Stats
- 10 US patents issued
- 24 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 10 US Patents Issued
- 24 US Applications Filed
- 90 Total Citation Count
- Jun 20, 2022 Most Recent Filing
- Sep 13, 2006 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
HARBOR THERAPEUTICS, INC. | 1
| 2014
|
GILEAD SCIENCES, INC. | 2
| 2015
|
LAURUS LABS LIMITED | 2
| 2011
|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 1
2 | 2006
2009 |
CYMABAY THERAPEUTICS, INC. | 2
2 2 | 2010
2013 2014 |
NEURMEDIX, INC. | 2
2 5 2 | 2009
2012 2014 2016 |
Inventor Addresses
Address | Duration |
---|---|
Bend, OR, US | Oct 28, 21 - Nov 07, 23 |
West Lafayette, IN | Mar 22, 07 - Mar 22, 07 |
West Lafayette, IN, US | Nov 26, 09 - Dec 21, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 3 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 16 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2023/0404,939 | 2023 | SOLID FORMS OF CANNABIDIOL AND USES THEREOF | 0 |
11807627 | 2023 | Morphic forms of complement factor D inhibitors | 2 |
11364202 | 2022 | Solid forms of cannabidiol and uses thereof | 0 |
2022/0160,713 | 2022 | SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | 0 |
2022/0002,338 | 2022 | CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.